<?xml version="1.0" encoding="UTF-8"?>
<collection xmlns="http://www.loc.gov/MARC21/slim">
 <record>
  <leader>     caa a22        4500</leader>
  <controlfield tag="001">475782380</controlfield>
  <controlfield tag="003">CHVBK</controlfield>
  <controlfield tag="005">20180406123648.0</controlfield>
  <controlfield tag="007">cr unu---uuuuu</controlfield>
  <controlfield tag="008">170329e20000601xx      s     000 0 eng  </controlfield>
  <datafield tag="024" ind1="7" ind2="0">
   <subfield code="a">10.1023/A:1008977806693</subfield>
   <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="035" ind1=" " ind2=" ">
   <subfield code="a">(NATIONALLICENCE)springer-10.1023/A:1008977806693</subfield>
  </datafield>
  <datafield tag="245" ind1="0" ind2="0">
   <subfield code="a">Processing and properties of two different poly (ortho esters)</subfield>
   <subfield code="h">[Elektronische Daten]</subfield>
   <subfield code="c">[M. Kellomäki, J. Heller, P. Törmälä]</subfield>
  </datafield>
  <datafield tag="520" ind1="3" ind2=" ">
   <subfield code="a">Processing and properties of two structurally different poly (ortho esters) (POE) and their in vitro behavior have been compared. One POE was a copolymer of diketene acetal 3,9-diethylidene-2,4,8,10-tetraoxaspiro[5.5]undecane, trans-cyclohexanedimethanol and polyacetal. The other POE was a copolymer of diketene acetal 3,9-diethylidene-2,4,8,10-tetraoxaspiro[5.5]undecane, trans-cyclohexanedimethanol and trans-cyclohexanedimethanol-dilactide. The polyacetal POE was also used as a matrix incorporating two different model drugs, caffeine and furosemide. Both polymers were ultrasonically molded into slabs. The lactide modified POE was also melt-extruded into rods and self-reinforced using a solid state die-drawing technique. The initial strength values of both ultrasonically molded and extruded samples were close to those of non-oriented poly lactic acids. Self-reinforcing increased the shear strength, bending strength and modulus of the rods from 41.7±1.7 MPa to 66.7±2.3 MPa, from 78.5±22.8 MPa to 183±23 MPa and from 2.5±0.3 GPa to 4.4±0.3 GPa, respectively. In vitro hydrolysis of samples was studied either in phosphate buffer saline (PBS) or in simulated body fluid (SBF) at 37 °C. Samples degraded faster in unchanged PBS than in PBS changed weekly. The total in vitro strength retention time was relatively short varying from 14 days to 42 days depending on the processing method and polymer type. Samples retained their wet weight at initial level for a longer time but dry weight started to decrease already after the first in vitro week. Polymers or degradation products crystallized in SBF but remained amorphous when hydrolyzed in PBS. Some of the devices showed evidence of surface erosion, and the processing method affected the erosion. The storage time of these polymers was found to be limited. However, both polymers were found to be of interest in bone fixation and tissue engineering. ©2000 Kluwer Academic Publishers</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
   <subfield code="a">Kluwer Academic Publishers, 2000</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Kellomäki</subfield>
   <subfield code="D">M.</subfield>
   <subfield code="u">Institute of Biomaterials, Tampere University of Technology, P.O. Box 589, 33101, Tampere, Finland</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Heller</subfield>
   <subfield code="D">J.</subfield>
   <subfield code="u">Advanced Polymer Systems, 123 Saginaw Drive, 94063, Redwood City, CA, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Törmälä</subfield>
   <subfield code="D">P.</subfield>
   <subfield code="u">Institute of Biomaterials, Tampere University of Technology, P.O. Box 589, 33101, Tampere, Finland</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="773" ind1="0" ind2=" ">
   <subfield code="t">Journal of Materials Science: Materials in Medicine</subfield>
   <subfield code="d">Kluwer Academic Publishers</subfield>
   <subfield code="g">11/6(2000-06-01), 345-355</subfield>
   <subfield code="x">0957-4530</subfield>
   <subfield code="q">11:6&lt;345</subfield>
   <subfield code="1">2000</subfield>
   <subfield code="2">11</subfield>
   <subfield code="o">10856</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2="0">
   <subfield code="u">https://doi.org/10.1023/A:1008977806693</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="908" ind1=" " ind2=" ">
   <subfield code="D">1</subfield>
   <subfield code="a">research-article</subfield>
   <subfield code="2">jats</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">856</subfield>
   <subfield code="E">40</subfield>
   <subfield code="u">https://doi.org/10.1023/A:1008977806693</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Kellomäki</subfield>
   <subfield code="D">M.</subfield>
   <subfield code="u">Institute of Biomaterials, Tampere University of Technology, P.O. Box 589, 33101, Tampere, Finland</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Heller</subfield>
   <subfield code="D">J.</subfield>
   <subfield code="u">Advanced Polymer Systems, 123 Saginaw Drive, 94063, Redwood City, CA, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Törmälä</subfield>
   <subfield code="D">P.</subfield>
   <subfield code="u">Institute of Biomaterials, Tampere University of Technology, P.O. Box 589, 33101, Tampere, Finland</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">773</subfield>
   <subfield code="E">0-</subfield>
   <subfield code="t">Journal of Materials Science: Materials in Medicine</subfield>
   <subfield code="d">Kluwer Academic Publishers</subfield>
   <subfield code="g">11/6(2000-06-01), 345-355</subfield>
   <subfield code="x">0957-4530</subfield>
   <subfield code="q">11:6&lt;345</subfield>
   <subfield code="1">2000</subfield>
   <subfield code="2">11</subfield>
   <subfield code="o">10856</subfield>
  </datafield>
  <datafield tag="900" ind1=" " ind2="7">
   <subfield code="a">Metadata rights reserved</subfield>
   <subfield code="b">Springer special CC-BY-NC licence</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="898" ind1=" " ind2=" ">
   <subfield code="a">BK010053</subfield>
   <subfield code="b">XK010053</subfield>
   <subfield code="c">XK010000</subfield>
  </datafield>
  <datafield tag="949" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="F">NATIONALLICENCE</subfield>
   <subfield code="b">NL-springer</subfield>
  </datafield>
 </record>
</collection>
